White House Announces Deal to Provide 150 Million Rapid Coronavirus Tests
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read MorePosted by Laurie Bonner | Aug 28, 2020 | Company News, Covid 19 |
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Compliance, Covid 19 |
A memo recommends that facilities conducting patient lab tests use authorized detection antigens to prevent the spread of covid-19 in nursing homes.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The Advanta Dx SARS-CoV-2 saliva-based RT-PCR Assay is an extraction-free test to detect nucleic acid from the SARS‑CoV‑2 virus, which causes covid-19.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Company News, Covid 19 |
Fulgent Houston will focus on covid-19 testing initially, with capacity for 20,000 tests per day and the ability to expand as demand continues to increase.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Company News, Covid 19 |
Under the contract, Hologic will expand production of custom sample collection and processing consumables for covid-19 tests.
Read More